169 related articles for article (PubMed ID: 30996686)
1. Stimulative role of ST6GALNAC1 in proliferation, migration and invasion of ovarian cancer stem cells via the Akt signaling pathway.
Wang WY; Cao YX; Zhou X; Wei B; Zhan L; Sun SY
Cancer Cell Int; 2019; 19():86. PubMed ID: 30996686
[TBL] [Abstract][Full Text] [Related]
2. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
3. ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.
Ogawa T; Hirohashi Y; Murai A; Nishidate T; Okita K; Wang L; Ikehara Y; Satoyoshi T; Usui A; Kubo T; Nakastugawa M; Kanaseki T; Tsukahara T; Kutomi G; Furuhata T; Hirata K; Sato N; Mizuguchi T; Takemasa I; Torigoe T
Oncotarget; 2017 Dec; 8(68):112550-112564. PubMed ID: 29348846
[TBL] [Abstract][Full Text] [Related]
4. γ-Secretase Inhibitor, DAPT Inhibits Self-renewal and Stemness Maintenance of Ovarian Cancer Stem-like Cells In Vitro.
Jiang LY; Zhang XL; Du P; Zheng JH
Chin J Cancer Res; 2011 Jun; 23(2):140-6. PubMed ID: 23482909
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract][Full Text] [Related]
7. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
8. ST6GALNAC1 promotes the invasion and migration of breast cancer cells via the EMT pathway.
Luo Y; Cao H; Lei C; Liu J
Genes Genomics; 2023 Nov; 45(11):1367-1376. PubMed ID: 37747641
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches.
Zhang X; Su Y; Wu X; Xiao R; Wu Y; Yang B; Wang Z; Guo L; Kang X; Wang C
J Ovarian Res; 2020 Sep; 13(1):116. PubMed ID: 32977853
[TBL] [Abstract][Full Text] [Related]
10. HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis.
Zhang Y; Guo J; Cai E; Cai J; Wen Y; Lu S; Li X; Han Q; Jiang J; Li T; Wang Z
Exp Cell Res; 2020 Oct; 395(2):112218. PubMed ID: 32771526
[TBL] [Abstract][Full Text] [Related]
11. LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a.
Hou R; Jiang L
Cancer Cell Int; 2021 Jul; 21(1):360. PubMed ID: 34238293
[TBL] [Abstract][Full Text] [Related]
12. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.
Zhang T; Xu J; Deng S; Zhou F; Li J; Zhang L; Li L; Wang QE; Li F
PLoS One; 2018; 13(5):e0196351. PubMed ID: 29723215
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion.
Chen Q; Liu X; Xu L; Wang Y; Wang S; Li Q; Huang Y; Liu T
Oncol Rep; 2016 Apr; 35(4):1916-24. PubMed ID: 26783004
[TBL] [Abstract][Full Text] [Related]
14. GATA1 gene silencing inhibits invasion, proliferation and migration of cholangiocarcinoma stem cells via disrupting the PI3K/AKT pathway.
Shi G; Zhang H; Yu Q; Hu C; Ji Y
Onco Targets Ther; 2019; 12():5335-5354. PubMed ID: 31456644
[No Abstract] [Full Text] [Related]
15. Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269636
[TBL] [Abstract][Full Text] [Related]
16. SNORA72 Activates the Notch1/c-Myc Pathway to Promote Stemness Transformation of Ovarian Cancer Cells.
Zhang L; Ma R; Gao M; Zhao Y; Lv X; Zhu W; Han L; Su P; Fan Y; Yan Y; Zhao L; Ma H; Wei M; He M
Front Cell Dev Biol; 2020; 8():583087. PubMed ID: 33224949
[TBL] [Abstract][Full Text] [Related]
17. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.
Liu M; Mor G; Cheng H; Xiang X; Hui P; Rutherford T; Yin G; Rimm DL; Holmberg J; Alvero A; Silasi DA
Reprod Sci; 2013 May; 20(5):605-15. PubMed ID: 23171677
[TBL] [Abstract][Full Text] [Related]
18. Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
Peng Q; Qin J; Zhang Y; Cheng X; Wang X; Lu W; Xie X; Zhang S
J Exp Clin Cancer Res; 2017 Nov; 36(1):171. PubMed ID: 29187221
[TBL] [Abstract][Full Text] [Related]
19. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
